- Home
- ACHV vs BLNK Comparison
ACHV vs BLNK Comparison
Compare ACHV & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- BLNK
- Stock Information
- Founded
- ACHV N/A
- BLNK 2009
- Country
- ACHV United States
- BLNK United States
- Employees
- ACHV N/A
- BLNK N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BLNK Industrial Specialties
- Sector
- ACHV Health Care
- BLNK Consumer Discretionary
- Exchange
- ACHV Nasdaq
- BLNK Nasdaq
- Market Cap
- ACHV 153.8M
- BLNK 129.3M
- IPO Year
- ACHV N/A
- BLNK N/A
- Fundamental
- Price
- ACHV $3.15
- BLNK $2.00
- Analyst Decision
- ACHV Strong Buy
- BLNK Buy
- Analyst Count
- ACHV 2
- BLNK 8
- Target Price
- ACHV $16.00
- BLNK $2.54
- AVG Volume (30 Days)
- ACHV 867.2K
- BLNK 4.9M
- Earning Date
- ACHV 11-06-2025
- BLNK 11-06-2025
- Dividend Yield
- ACHV N/A
- BLNK N/A
- EPS Growth
- ACHV N/A
- BLNK N/A
- EPS
- ACHV N/A
- BLNK N/A
- Revenue
- ACHV N/A
- BLNK $104,788,000.00
- Revenue This Year
- ACHV N/A
- BLNK N/A
- Revenue Next Year
- ACHV N/A
- BLNK $19.30
- P/E Ratio
- ACHV N/A
- BLNK N/A
- Revenue Growth
- ACHV N/A
- BLNK N/A
- 52 Week Low
- ACHV $1.84
- BLNK $0.63
- 52 Week High
- ACHV $5.31
- BLNK $2.32
- Technical
- Relative Strength Index (RSI)
- ACHV 56.75
- BLNK 76.13
- Support Level
- ACHV $3.07
- BLNK $1.47
- Resistance Level
- ACHV $3.21
- BLNK $1.82
- Average True Range (ATR)
- ACHV 0.14
- BLNK 0.15
- MACD
- ACHV 0.01
- BLNK 0.04
- Stochastic Oscillator
- ACHV 77.55
- BLNK 80.90
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.